Alphabet Inc. (GOOGL) vs. Elevance Health, Inc. (ELV) Stock Comparison & Valuation | Edwyn

Edwyn

Edwyn Search companies, tickers, CIKs…⌘K

Alphabet Inc. (GOOGL) vs. Elevance Health, Inc. (ELV) Stock Comparison & Valuation | Edwyn

Updated 2026-08-03 20:46 UTC

This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.

GOOGL screens as fundamentally superior to ELV on growth and profitability, but the relative valuation context is distorted because the provided implied price appears far below GOOGL's historical and DCF ranges, making the comparison supportive of quality but not a clean bargain signal.

Actionable Takeaway

If you believe GOOGL can sustain its 15.1% revenue growth and 32.0% operating margin without a material multiple compression, then hold or add to GOOGL because its fundamental quality is clearly stronger than ELV's even though ELV-based valuation output shows a large discount to the current price.

On the provided P/E-based implied price, GOOGL's $356.13 current price compares with an implied price of $161.16, implying -54.7% downside in this framework. However, that implied value sits well below both the historical band of $281.70-$344.30 and the DCF range of $108.58-$146.90, suggesting the relative multiple setup is internally inconsistent or at least highly sensitive to the chosen ELV anchor.

Supporting Metrics

Key Risks

ELV-based implied price for GOOGL is $161.16, which corresponds to -54.7% upside/downside and creates a major valuation overhang.
GOOGL's Piotroski F-Score of 5/9 is only moderate, so the current quality signal is not especially strong.
DCF range of $108.58-$146.90 is well below GOOGL's $356.13 current price, suggesting downside risk if cash flow assumptions prove conservative.